sinofour undertakes the automation project (DCS+BMS+GDS+SIS) for Hanrui Pharmaceutical Co., Ltd. Workshop 103, and it has been perfectly completed
ABOUT HIRAY
The API + CDMO R&D and production base of Hiray Pharma Solutions Ltd., is located at the intersection of the Yangtze River Economic Belt and the Hanjiang Economic Belt - Jingmen Chemical Recycling Industrial Park, Hubei Province.
Hanrui Pharmaceuticals (Jingmen) is a wholly-owned subsidiary of Wuhan Hightop Biotech Pharmaceutical Co., Ltd. It covers an area of 310 mu (210 mu under construction, 100 mu reserved) and includes 3 GMP multifunctional workshops, 4 GMP commercial workshops, and 6 Non-GMP workshops. The equipment volume ranges from 30L to 10000L, covering high and low-temperature processes, as well as hydrogenation.
Hanrui is committed to intelligent manufacturing to support the development of green APIs (Active Pharmaceutical Ingredients) and provides high-quality CDMO (Contract Development and Manufacturing Organization) services to Big Pharma & Biotech. We are dedicated to engaging in the health industry in a responsible manner.
Process Description: The equipment in this project includes hydrogenation reactor, multi-functional synthesis reactor, single and double cone dryers, centrifuges, and utility engineering equipment.
The main functions are automatic material transfer, replenishment, temperature control of the reaction vessel, nitrogen purging, and inert gas tightness testing. We provide a complete set of GMP validation documents compliant with FDA standards.
English
中文